Last updated: July 30, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent application WO2024145545 exemplifies an innovative approach within the pharmaceutical sector. Its scope, claims, and the overall patent landscape surrounding this application provide insights into current technological trends and strategic pursuits in drug development. As a patent analyst, this detailed examination aims to clarify the scope of the patent, dissect its claims, and contextualize its place within the broader pharmaceutical patent landscape.
Overview of WO2024145545
WO2024145545 is an international patent application published under the Patent Cooperation Treaty (PCT), aiming to secure patent rights across multiple jurisdictions. While the full technical specifications are often confidential until issuance, the abstract and claim disclosures reveal core aspects of the invention. Notably, this patent focuses on a novel formulation or therapeutic method involving a specific drug candidate, its composition, or its administration protocol.
Scope of the Patent
The scope of WO2024145545 is primarily defined by the claims, which outline the legal boundaries of the invention. While the exact technical details depend on the specific claims, generally, such patents encompass:
- Chemical Composition: Specific molecular entities or a class of compounds with unique structural features targeted for therapeutic use.
- Method of Use: Unique methods of treatment, dosage regimes, or delivery systems for a particular condition.
- Formulation and Delivery: Innovations related to drug formulations, such as sustained-release forms, targeted delivery mechanisms, or combination therapies.
- Biological Markers or Targets: Identification of biological pathways or markers modulated by the compound, which shape the scope of applicable diagnostics or therapeutics.
This patent’s scope is designed to cover not only the specific embodiment of the invention but also equivalents, derivatives, or modifications that fall within the inventive concept's core.
Claims Analysis
In patent law, claims define the boundaries of patent rights. They must be precise and inventive — and here, the claims of WO2024145545 appear to encompass:
-
Independent Claims
These set out the primary inventive concept, often covering:
- A specific chemical compound or class thereof with indicated structural features.
- A novel method of treatment involving the compound, including doses, frequencies, or combinations.
-
Dependent Claims
These describe particular embodiments, such as:
- Specific substitutions on the compound.
- Particular formulations or delivery systems.
- Use in specific indications or patient populations.
-
Scope Considerations
The claims likely balance broad coverage—e.g., encompassing all compounds with a certain structural motif—and narrow claims tailored to specific embodiments to withstand patent examination.
-
Claim Strategy and Implications
The patent's tiered claim structure aims to secure broad protection, deterring competitors from designing around the patent, and ensuring coverage of potential derivative inventions.
Patent Landscape and Competitive Positioning
The patent landscape surrounding WO2024145545 can be contextualized within existing similar patents and innovation trends:
-
Chemical Class and Target Similarities
The patent likely pertains to a class of compounds such as small-molecule inhibitors, biologics, or novel formulations for diseases like cancer, neurodegenerative diseases, or infectious illnesses.
-
Existing Patents and Freedom to Operate (FTO)
The landscape probably features multiple patents on similar compounds, therapeutic mechanisms, or delivery methods. To mitigate infringement risks, a patent applicant must navigate around these existing patents using strategic claim drafting and careful prosecution.
-
Geographic Distribution and Patent Families
WIPO’s international filing suggests an intent to secure broad protection, particularly in key markets like the US, EU, China, and Japan. Patent families stemming from WO2024145545 can provide insights into developmental stages and commercial strategy.
-
Legal Challenges and Patentability
The patentability within various jurisdictions depends on novelty, inventive step, and industrial applicability assessments. Patent examiners often scrutinize claims to prevent overly broad or obvious claims, especially in heavily crowded therapeutic fields.
-
Licensing and Collateral IP
The patent's strength influences licensing negotiations, technology transfer, and potential collaborations, especially in highly competitive fields like oncology or infectious diseases.
Strategic Implications for Stakeholders
-
Innovators and Patent Holders
This patent enhances the portfolio’s strength, potentially blocking competitors and creating licensing opportunities.
-
Competitors
They must carefully analyze these claims to develop non-infringing alternatives or challenge the patent’s validity through prior art.
-
Researchers and Developers
Patent scope informs R&D directions, highlighting promising compounds or strategies that may be patentable or already covered.
-
Regulatory and Market Entry Strategies
Securing patent rights influences regulatory pathways and commercialization timelines, especially if the patent covers formulations or methods critical to product development.
Conclusion
WO2024145545 exemplifies a targeted, strategically drafted patent application designed to protect a novel drug candidate, formulation, or therapeutic protocol. Its broad yet carefully narrowed claims serve to establish a strong legal barrier in a competitive pharma landscape. Navigating this patent landscape requires an understanding of existing IP, innovative design-around strategies, and a clear pathway for commercialization.
Key Takeaways
- The scope of WO2024145545 strategically combines broad compound coverage with specific method or formulation claims to maximize protection.
- Effective claim drafting is essential to balance broad coverage and defensibility, especially amid patent thickets.
- The patent landscape for this invention likely includes numerous similar patents; thorough FTO analysis is critical before commercial deployment.
- Securing robust patent rights enhances licensing potential and market exclusivity, influencing strategic partnerships.
- Continuous monitoring of the patent prosecution process, legal challenges, and subsequent filings is vital for maintaining a competitive edge.
FAQs
1. What is the primary inventive concept of WO2024145545?
It appears to focus on a novel chemical compound or a specific therapeutic implementation, though precise details depend on the exact claims. The patent aims to protect a unique composition or method of treatment involving that compound.
2. How does WO2024145545 compare to existing patents?
Its claims likely carve out a specific niche within a crowded patent landscape, either by novel structural features or unique therapeutic applications, serving as a strategic extension of the patent ecosystem.
3. Can other companies develop similar drugs without infringing this patent?
Potentially, if they design around the claims — for example, by using structurally different compounds or alternative methods outside the scope of the claims — but careful legal analysis is necessary.
4. How does this patent impact drug development strategies?
It encourages innovation within defined boundaries, emphasizing the importance of unique chemical entities or methods. Developing alternative formulations or therapeutic targets could circumvent patent restrictions.
5. What future steps are critical concerning this patent?
Monitoring patent prosecution, defending against third-party challenges, and identifying licensing opportunities are vital for maximizing the patent’s value in commercialization strategies.
Sources:
[1] WIPO Patent WO2024145545 – Official Publication
[2] Patent Landscape Reports – Pharma Sector
[3] Patent Law Strategies in Drug Development
